Scientific Publications

Find here relevant scientific publications related to Marinomeds research as well as publications related to our research areas.

Virology Marinomed
Morokutti-Kurz et al., PLoS ONE, 2021, 16(2): e0237480.
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro (882 KB)
Virology Marinomed
Fröba et al., Int. J. Mol. Sci. 2021, 22, 13202
Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta (2 MB)
Virology Marinomed
Morokutti-Kurz M et al., Int J Gen Med. 2021;14:5241-5249
The Saliva of Probands Sucking an Iota-Carrageenan Containing Lozenge Inhibits Viral Binding and Replication of the Most… (1,002 KB)
Virology Marinomed
Morokutti-Kurz et al., bioRxiv. 2020; 10.1101/2020.07.28.224733
SARS-CoV-2 in-vitro neutralization assay reveals inhibition of virus entry by iota-carrageenan (256 KB)
Virology Marinomed
Graf et al., International Journal of General Medicine 2018, 11:275–28
Development of a nasal spray containing xylometazoline hydrochloride and iota- carrageenan for the symptomatic relief of… (524 KB)
Virology Marinomed
Morokutti-Kurz et al., International Journal of General Medicine 2017, 10:53–60
Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat (2 MB)
Virology Marinomed
Hebar et al., PLOS one 2015, 10:4
Non-Clinical Safety Evaluation of Intranasal Iota-Carrageenan (287 KB)
Virology Marinomed
Morokutti-Kurz et al., PLOS one 2015, 10:6
The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the… (693 KB)
Virology Marinomed
Koenighofer et al., Multidisciplinary Respiratory Medicine 2014, 9:57
Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled… (1 MB)
Virology Marinomed
Nakowitsch et al. 2013
Combination of a corticosteroid and an anti-viral intranasal therapy (393 KB)
Virology Marinomed
Ludwig et al., Respiratory Research 2013, 14:124
Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial (518 KB)
Virology Marinomed
Fazekas et al., BMC Complementary and Alternative Medicine 2012, 12:147
Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical… (754 KB)
Virology Marinomed
Leibbrandt et al., PLOS one 2010, 5:12
Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection (1 MB)
Virology Marinomed
Eccles et al., Respiratory Research 2010, 11:108
Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled… (371 KB)
Virology Marinomed
Grassauer et al., Virology Journal 2008, 5:107
Iota-Carrageenan is a potent inhibitor of rhinovirus infection (395 KB)
Virology Related
Bovard et al., Biochemistry and Biophysics Reports, Volume 29, 2022, 101187
Iota-carrageenan extracted from red algae is a potent inhibitor of SARS‐CoV-2 infection in reconstituted human airway… (3 MB)
Virology Related
Bansal et al., PLoS ONE 2021; 16(11): e0259943.
Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture (1 MB)
Virology Related
Chahla et al., medRxiv 2021; 03.26.21254398;
A randomized trial - intensive treatment based in Ivermectin and Iota-Carrageenan as pre-exposure prophylaxis for… (198 KB)
Virology Related
Hemilä et al., Pharmacology Research & Perspectives 2021; DOI: 10.1002/prp2.810
Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of… (759 KB)
Virology Related
Bichiri et al., Med Pharm Rep. 2021 Jan; 94(1): 28–34.
Safety and efficacy of iota-carrageenan nasal spray in treatment and prevention of the common cold (395 KB)
Virology Related
Alsaidi et al., Mar. Drugs 2021, 19, 418.
Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model (530 KB)
Virology Related
M. Suchomel et. al; Austrian Society for Hygiene, Microbiology and Preventive Medicine
Use of gargle solutions and nasal sprays - two other allies in the defense against viral colds even in times of Covid-19… (188 KB)
Virology Related
Figueroa et al., Int J Gen Med. 2021;14:6277-6286
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel… (3 MB)
Virology Related
Schütz et al., American Journal of Physiology-Lung Cellular and Molecular Physiology, 2021
Carrageenan containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures (517 KB)
Virology Related
Ratcliffe et al., PLoS Pathog 2021; 17(11): e1010079
Nasal therapy — The missing link in optimising strategies to improve prevention and treatment of COVID-19 (355 KB)
Virology Related
Auth, J. et al., Int. J. Mol. Sci. 2021, 22, 10205.
Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta (2 MB)
Virology Related
Amtha et al., Teikyo Medical Journal; 2021, 44 (05), 1659-1669
PVP-I and Iota-Carrageenan Improve Subjective Clinical Symptoms In COVID-19 Emergency Hospital Wisma Atlet, Indonesia: A… (270 KB)
Virology Related
Hoseini-Tavassol et al., Infectious Disorders - Drug Targets, 2021, 20, 1-7
Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control (527 KB)
Virology Related
Kramer et al., GMS Hygiene and Infection Control 2021, Vol. 16, ISSN 2196-5226
Virucidal gargling and virucidal nasal spray (157 KB)
Virology Related
Chen et al., International Journal of Biological Macromolecules, 2020, 164, 331-343
Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines (3 MB)
Virology Related
Clausen et al., Cell 2020, 2020.09.033
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 (3 MB)
Virology Related
Bansal et al., bioRxiv. 2020; 10.1101/2020.08.19.225854
Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture (348 KB)
Virology Related
Hirsch et al., Journal of Infectious Diseases & Travel Medicine 2020, 4 (S1): 000S1-007
Covid 19 and Ivermectin Prevention and Treatment Update (229 KB)
Virology Related
Lee, Marine Drugs 2020, 18, 435
Carrageenans as Broad-Spectrum Microbicides: Current Status and Challenges (664 KB)
Virology Related
Pereira, L., Critchley, A.T., Journal of Applied Phycology 2020
The COVID 19 novel coronavirus pandemic 2020: seaweeds to the rescue? Why does substantial, supporting research about… (193 KB)
Virology Related
Carvallo et al., Journal of Biomedical Research and Clinical Investigation 2020; Volume 2 Isue 1.1007
Study of the Efficacy and Safety of Topical Ivermectin + Iota-Carrageenan in the Prophylaxis against COVID-19 in Health… (600 KB)
Virology Related
Eccles, The Open Virology Journal 2020, 14:9
Iota-Carrageenan as an Antiviral Treatment for the Common Cold (3 MB)
Virology Related
Eccles et al., Respiratory Research 2015, 16:121
Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the… (914 KB)
Immunology Marinomed
Nakowitsch et al., Pharmaceutics 2020, 12(9), 847
Saponin Micelles Lead to High Mucosal Permeation and In Vivo Efficacy of Solubilized Budesonide (1 MB)
Immunology Marinomed
Zieglmayer et al., Clin Exp Allergy. 2020; 00:1–13.
Fast effectiveness of a solubilized low‐dose budesonide nasal spray in allergic rhinitis (1 MB)
Immunology Marinomed
Zhang et al., Invest Ophthalmol Vis Sci. 2020; 61(1):4.
Topical Pergolide Enhance Corneal Nerve Regrowth Following Induced Corneal Abrasion (2 MB)
Immunology Marinomed
Siegl et al., European Journal of Pharmaceutics and Biopharmaceutics 134, 2019, 88-95
Pharmacokinetics of topically applied tacrolimus dissolved in Marinosolv, a novel aqueous eye drop formulation (5 MB)
Immunology Related
Markus et al., PLOS one 2014, 9:2
Non-Invasive Optical Imaging of Eosinophilia during the Course of an Experimental Allergic Airways Disease Model and in… (3 MB)
Lucia Mayr-Harting, MSc
Public Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com